Drug Shortage Report for MALARONE PEDIATRIC
| Report ID | 190045 |
| Drug Identification Number | 02264935 |
| Brand name | MALARONE PEDIATRIC |
| Common or Proper name | atovaquone and proguanil hydrochloride tablets |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PROGUANIL HYDROCHLORIDE ATOVAQUONE |
| Strength(s) | 25.0MG 62.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 12s |
| ATC code | P01BB |
| ATC description | ANTIMALARIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-04-17 |
| Estimated end date | Unknown |
| Actual end date | 2023-06-19 |
| Shortage status | Resolved |
| Updated date | 2023-06-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-06-21 | French | Compare |
| v3 | 2023-06-21 | English | Compare |
| v2 | 2023-04-21 | French | Compare |
| v1 | 2023-04-21 | English | Compare |
Showing 1 to 4 of 4